We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA DENIES MYLAN'S CITIZEN PETITION ON AUTHORIZED GENERICS
FDA DENIES MYLAN'S CITIZEN PETITION ON AUTHORIZED GENERICS
July 2, 2004
The FDA has denied citizen petitions submitted by two prominent generic drugmakers seeking to prohibit the marketing of authorized generic drugs during another generic firm's 180-day exclusivity period.